Unmet Needs In Multiple Myeloma Management

Now Viewing

EP: 1.Unmet Needs In Multiple Myeloma Management

EP: 2.Evolving Goals in Multiple Myeloma Treatment

EP: 3.Multiple Myeloma Induction Challenges and Future Options

EP: 4.Optimizing Multiple Myeloma Treatment: Quadruplet Therapy

EP: 5.Real-World Insights: Multiple Myeloma Treatment Challenges

EP: 6.Navigating the Multiple Myeloma Treatment Landscape

EP: 7.Real-world Multiple Myeloma Treatment: Insights and Challenges

EP: 8.The Future of Multiple Myeloma Treatment

EP: 9.ASH 2023: Multiple Myeloma's Shifting Landscape: Trials and Clinical Perspectives

EP: 10.Multiple Myeloma Frontline Horizon: Quads, Bispecifics, and Breakthroughs

This is a video synopsis/summary of a Peer Exchange featuring Joshua Richter, MD; Rafat Abonour, MD; Faith Davies, MD; and Amrita Krishnan, MD.

Experts Richter, Abonour, Davies, and Krishnan discuss the current landscape of frontline treatment options for multiple myeloma. Abonour emphasizes the challenges in managing high-risk patients and highlights the need for tailored approaches. Other essential topics the panel discusses include the role of consolidation therapy and the significance of minimal residual disease testing in treatment decisions. Richter and Davies focus on the increasing prevalence of myeloma, with approximately 35,000 new cases in the US annually. The racial disparities in myeloma incidence, particularly among African Americans, are acknowledged. The experts stress the importance of addressing unmet needs, including a focus on achieving cures and optimizing treatment for older and frail patients. The discussion sets the stage for exploring emerging therapies and trends at the 2023 American Society of Hematology Annual Meeting and Exposition (ASH 2023).

Video synopsis is AI-generated and reviewed by AJMC^® editorial staff.